Fig. 1From: Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case reportClinical course of the patient. The hemoglobin concentration, platelet count, and white blood cell count are represented by lines. The percentage of reticulocytes is represented by gray bars. CERA continuous erythropoietin receptor activator (epoetin β pegol), DPO darbepoetin α, EPOα epoetin αBack to article page